These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation. Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187 [TBL] [Abstract][Full Text] [Related]
25. Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: an in-vitro study in healthy humans. Fanigliulo D; Lazzerini PE; Capecchi PL; Ulivieri C; Baldari CT; Laghi-Pasini F Int Immunopharmacol; 2015 Feb; 24(2):276-284. PubMed ID: 25536542 [TBL] [Abstract][Full Text] [Related]
26. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. Shima T; Sasaki Y; Itoh M; Nakashima A; Ishii N; Sugamura K; Saito S J Reprod Immunol; 2010 Jun; 85(2):121-9. PubMed ID: 20439117 [TBL] [Abstract][Full Text] [Related]
27. mTOR Signaling Regulates Protective Activity of Transferred CD4+Foxp3+ T Cells in Repair of Acute Kidney Injury. Chen G; Dong Z; Liu H; Liu Y; Duan S; Liu Y; Liu F; Chen H J Immunol; 2016 Nov; 197(10):3917-3926. PubMed ID: 27798166 [TBL] [Abstract][Full Text] [Related]
28. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma. Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102 [TBL] [Abstract][Full Text] [Related]
29. Tanshinol suppresses cardiac allograft rejection in a murine model. Lu C; Zeng YQ; Liu H; Xie Q; Xu S; Tu K; Dou C; Dai Z J Heart Lung Transplant; 2017 Feb; 36(2):227-236. PubMed ID: 27574736 [TBL] [Abstract][Full Text] [Related]
30. Rapamycin promotes the expansion of CD4(+) Foxp3(+) regulatory T cells after liver transplantation. Lu L; Qian XF; Rao JH; Wang XH; Zheng SG; Zhang F Transplant Proc; 2010 Jun; 42(5):1755-7. PubMed ID: 20620516 [TBL] [Abstract][Full Text] [Related]
31. Depletion of FoxP3 Wang J; Müller S; Lin R; Siffert M; Vuitton DA; Wen H; Gottstein B Immun Inflamm Dis; 2017 Dec; 5(4):435-447. PubMed ID: 28621034 [TBL] [Abstract][Full Text] [Related]
32. Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. Singh K; Stempora L; Harvey RD; Kirk AD; Larsen CP; Blazar BR; Kean LS Am J Transplant; 2014 Dec; 14(12):2691-703. PubMed ID: 25359003 [TBL] [Abstract][Full Text] [Related]
33. Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment. Schwaiger T; van den Brandt C; Fitzner B; Zaatreh S; Kraatz F; Dummer A; Nizze H; Evert M; Bröker BM; Brunner-Weinzierl MC; Wartmann T; Salem T; Lerch MM; Jaster R; Mayerle J Gut; 2014 Mar; 63(3):494-505. PubMed ID: 23564336 [TBL] [Abstract][Full Text] [Related]
34. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice. Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841 [TBL] [Abstract][Full Text] [Related]
35. The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts. Urbanellis P; Shyu W; Khattar R; Wang J; Zakharova A; He W; Sadozai H; Amir AZ; Shalev I; Phillips MJ; Adeyi O; Ross H; Grant D; Levy GA; Chruscinski A Immunology; 2015 Jan; 144(1):91-106. PubMed ID: 24990517 [TBL] [Abstract][Full Text] [Related]
36. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Kopf H; de la Rosa GM; Howard OM; Chen X Int Immunopharmacol; 2007 Dec; 7(13):1819-24. PubMed ID: 17996694 [TBL] [Abstract][Full Text] [Related]
37. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982 [TBL] [Abstract][Full Text] [Related]
38. Repeated Long-Term DT Application in the DEREG Mouse Induces a Neutralizing Anti-DT Antibody Response. Wang J; Siffert M; Spiliotis M; Gottstein B J Immunol Res; 2016; 2016():1450398. PubMed ID: 28074191 [TBL] [Abstract][Full Text] [Related]
39. Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity. Ghazal K; Stenard F; Dahlqvist G; Barjon C; Aoudjehane L; Scatton O; Conti F Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):237-244. PubMed ID: 29175009 [TBL] [Abstract][Full Text] [Related]
40. Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4-Ig. Oh B; Yoon J; Farris A; Kirk A; Knechtle S; Kwun J Am J Transplant; 2016 Sep; 16(9):2612-23. PubMed ID: 26990829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]